Get started
ReutersReuters

Novocure To Present Data From Phase 3 Panova-3 Trial Of Tumor Treating Fields In Pancreatic Cancer At Esmo Gastrointestinal Cancers Congress 2025

RefinitivLess than 1 min read
NVCR

Novocure Ltd NVCR:

  • NOVOCURE TO PRESENT FINAL SECONDARY ENDPOINT DATA FROM THE PHASE 3 PANOVA-3 TRIAL OF TUMOR TREATING FIELDS (TTFIELDS) IN PANCREATIC CANCER AT THE ESMO GASTROINTESTINAL CANCERS CONGRESS 2025

EuropeReutersUK stocksUnited Kingdom
refinitivrefinitiv
© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html
Login or create a forever free account to read this news

More news from Reuters